Cikkek nyilvánosan hozzáférhető megbízással - Tatjana PotparaTovábbi információ
Sehol sem hozzáférhető: 18
Management of atrial high-rate episodes detected by cardiac implanted electronic devices
B Freedman, G Boriani, TV Glotzer, JS Healey, P Kirchhof, TS Potpara
Nature Reviews Cardiology 14 (12), 701-714, 2017
Megbízások: British Heart Foundation, European Commission, Leducq Foundation, USA
The role of amiodarone in contemporary management of complex cardiac arrhythmias
N Mujović, D Dobrev, M Marinković, V Russo, TS Potpara
Pharmacological Research 151, 104521, 2020
Megbízások: US National Institutes of Health, German Research Foundation
Incident co-morbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in …
TF Chao, JN Liao, TC Tuan, YJ Lin, SL Chang, LW Lo, YF Hu, FP Chung, ...
Thrombosis and haemostasis 119 (07), 1162-1170, 2019
Megbízások: National Institute for Health Research, UK
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Cardiovascular Research 118 (7), 1618-1666, 2022
Megbízások: Swiss National Science Foundation, US National Institutes of Health …
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology
G Boriani, M Vitolo, DA Lane, TS Potpara, GYH Lip
European Journal of Internal Medicine 86, 1-11, 2021
Megbízások: National Institute for Health Research, UK
Stroke prevention strategies in high-risk patients with atrial fibrillation
A Kotalczyk, M Mazurek, Z Kalarus, TS Potpara, GYH Lip
Nature Reviews Cardiology 18 (4), 276-290, 2021
Megbízások: National Institute for Health Research, UK
Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation
Y Guo, H Wang, Y Tian, Y Wang, GYH Lip
Thrombosis and haemostasis 115 (01), 184-192, 2016
Megbízások: National Natural Science Foundation of China
Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation
TS Potpara, N Mujovic, B Sivasambu, A Shantsila, M Marinkovic, ...
International journal of cardiology 276, 130-135, 2019
Megbízások: National Institute for Health Research, UK
Rhythm-or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena …
VL Malavasi, M Vitolo, J Colella, F Montagnolo, M Mantovani, M Proietti, ...
Internal and emergency medicine 17 (4), 1001-1012, 2022
Megbízások: National Institute for Health Research, UK
Stroke prevention in atrial fibrillation
GYH Lip, Y Gue, J Zhang, TF Chao, H Calkins, T Potpara
Trends in cardiovascular medicine 32 (8), 501-510, 2022
Megbízások: National Institute for Health Research, UK
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry
JM Rivera-Caravaca, O Piot, I Roldán-Rabadán, A Denis, M Anguita, ...
EP Europace 24 (2), 202-210, 2022
Megbízások: German Research Foundation
Smart device-based detection of atrial fibrillation: Opportunities and challenges in the emerging world of digital health
D Dobrev, TS Potpara
International Journal of Cardiology 302, 108-109, 2020
Megbízások: US National Institutes of Health, German Research Foundation
Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey
M Kozieł, M Mihajlovic, M Nedeljkovic, N Pavlovic, V Paparisto, L Music, ...
International Journal of Cardiology 333, 105-109, 2021
Megbízások: National Institute for Health Research, UK
Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry
J Kornej, K Schumacher, P Sommer, T Potpara, A Arya, N Dagres, ...
EP Europace 21 (11), 1646-1652, 2019
Megbízások: National Institute for Health Research, UK
Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?
A Kotalczyk, YX Gue, TS Potpara, GYH Lip
Expert Opinion on Pharmacotherapy 22 (8), 1061-1070, 2021
Megbízások: National Institute for Health Research, UK
Prognostic implications of the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction
J Luo, Z Li, X Qin, X Zhang, X Liu, W Zhang, W Xu, Y Zhang, Y Fang, B Liu, ...
European Journal of Internal Medicine 113, 38-44, 2023
Megbízások: National Natural Science Foundation of China
Antithrombotic therapy: less is more or the more the better? Authors’ reply
TS Potpara, N Mujovic
EP Europace 22 (7), 1143-1143, 2020
Megbízások: National Natural Science Foundation of China
New-Onset Atrial Fibrillation in a Stable Patient with Remote Percutaneous Coronary Intervention
JM Ruiz-Nodar, TS Potpara, F Marín
Atrial Fibrillation and Percutaneous Coronary Intervention: A Case-based …, 2017
Megbízások: Government of Spain
Valahol hozzáférhető: 66
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The …
G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ...
European heart journal 42 (5), 373-498, 2021
Megbízások: British Heart Foundation
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
Megbízások: UK Medical Research Council
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.